Evidence map›Paper›PMID 34100231›Full record

ArticleJournal of general internal medicine2021

Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection.

Justin R Kingery, Paul Bf Martin, Ben R Baer, Laura C Pinheiro, Mangala Rajan, Adrienne Clermont, Sabrina Pan, Khoi Nguyen, Khalid Fahoum, Graham T Wehmeyer and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Justin R Kingery *Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA. jrk9006@med.cornell.edu.ORCID http://orcid.org/0000-0002-6788-1231
Paul Bf Martin *Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Ben R BaerDepartment of Statistics and Data Science, Cornell University, Ithaca, NY, USA.
Laura C PinheiroDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Mangala RajanDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Adrienne ClermontSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Sabrina PanSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Khoi NguyenSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Khalid FahoumSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Graham T WehmeyerSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Mark N AlshakSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Han A LiSchool of Medicine, Weill Cornell Medicine, New York, NY, USA.
Justin J ChoiDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Martin F ShapiroDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Margaret L McNairyDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Monika M SaffordDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Parag GoyalDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Cornell University · US

Funding

Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Institutional Career Development CoreKL2TR002385 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI YUAN-SHAN ZHU · 2017 to 2026
$13.3M
HIV-associated Myocardial Diastolic Dysfunction: A Prospective Cohort StudyK23HL152926 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KINGERY, JUSTIN ROY · 2020 to 2021
$388k
NCATS NIH HHS KL2 TR002385NCATS NIH HHS KL2-TR-002385NCATS NIH HHS UL1 TR000457NHLBI NIH HHS K23 HL152926NHLBI NIH HHS K23-HL-152926
6 · The paper itself

Abstract

backgroundThe clinical course of COVID-19 includes multiple disease phases. Data describing post-hospital discharge outcomes may provide insight into disease course. Studies describing post-hospitalization outcomes of adults following COVID-19 infection are limited to electronic medical record review, which may underestimate the incidence of outcomes.

objectiveTo determine 30-day post-hospitalization outcomes following COVID-19 infection.

designRetrospective cohort study

settingQuaternary referral hospital and community hospital in New York City.

participantsCOVID-19 infected patients discharged alive from the emergency department (ED) or hospital between March 3 and May 15, 2020. MEASUREMENT: Outcomes included return to an ED, re-hospitalization, and mortality within 30 days of hospital discharge.

resultsThirty-day follow-up data were successfully collected on 94.6% of eligible patients. Among 1344 patients, 16.5% returned to an ED, 9.8% were re-hospitalized, and 2.4% died. Among patients who returned to the ED, 50.0% (108/216) went to a different hospital from the hospital of the index presentation, and 61.1% (132/216) of those who returned were re-hospitalized. In Cox models adjusted for variables selected using the lasso method, age (HR 1.01 per year [95% CI 1.00-1.02]), diabetes (1.54 [1.06-2.23]), and the need for inpatient dialysis (3.78 [2.23-6.43]) during the index presentation were independently associated with a higher re-hospitalization rate. Older age (HR 1.08 [1.05-1.11]) and Asian race (2.89 [1.27-6.61]) were significantly associated with mortality.

conclusionsAmong patients discharged alive following their index presentation for COVID-19, risk for returning to a hospital within 30 days of discharge was substantial. These patients merit close post-discharge follow-up to optimize outcomes.

Indexed as

COVID-19Patient DischargeAdultAftercareAgedEmergency Service, HospitalHospitalizationHumansRetrospective StudiesSARS-CoV-2COVID-19dischargemortalityre-admission

Identifiers

PMID34100231
PMCPMC8183585
OpenAlexW3167661206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.